Last reviewed · How we verify
NCT02779712: ReCAST-2
Remote Ischaemic Conditioning After Stroke Trial (ReCAST-2)
Phase 2 trial testing Remote ischaemic conditioning in Stroke in 60 participants. Completed in 23 July 2018.
23 July 2018
Quick facts
| Lead sponsor | University of Nottingham |
|---|---|
| Phase | Phase 2 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 1 August 2016 |
| Primary completion | 23 July 2018 |
| Estimated completion | 23 July 2018 |
| Sites | 2 locations across United Kingdom |
Drugs / interventions tested
- Remote ischaemic conditioning
- Sham
Conditions studied
- Stroke — all drugs for Stroke →
Sponsor
University of Nottingham
Who can join
18 and older, any sex, with Stroke. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Stroke has an enormous impact on both individual and society. Novel treatments are required to relieve this burden and remote ischaemic conditioning (RIC) is one such approach. RIC refers to applying non-lethal ischaemia to an area distant from an organ you are trying to protect (e.g. the brain). Pre-clinical animal stroke studies have shown RIC to be neuroprotective and help restore functional outcome when compared to control. These outcomes are achieved simply by transiently occluding the blood supply to a limb (e.g. the arm) very soon after the stroke occurs. The mechanisms of protection are unclear but may be due enhancing the body's ability to protect itself from further injury by favorably altering cerebral blood flow or reducing the detrimental effects of oxygen free radicals. Ischaemic conditioning (IC) is an intervention already applied during cardiac surgery to protect the heart from damage and it may be effective after an acute myocardial infarction. The investigators therefore plan to conduct a pilot randomised controlled trial assessing the feasibility of applying RIC (4 cycles of blood pressure cuff inflation for 5 minutes) in patients within 6 hours of ischaemic stroke. The primary outcome is feasibility of RIC. Secondary outcomes include tolerability, safety and clinical efficacy. The results will inform the design of future trials of a potential intervention is that is pragmatic, non-invasive and simple to administer.
Publications & conference data
8 peer-reviewed publications reference this trial (live from Europe PMC):
-
Remote ischemic conditioning for stroke: clinical data, challenges, and future directions.
Zhao W, Li S, Ren C, Meng R, et al · · 2019 · cited 45× · PMID 30656197 · DOI 10.1002/acn3.691 -
Remote Ischemic Conditioning After Stroke Trial 2: A Phase IIb Randomized Controlled Trial in Hyperacute Stroke.
England TJ, Hedstrom A, O'Sullivan SE, Woodhouse L, et al · · 2019 · cited 44× · PMID 31747864 · DOI 10.1161/jaha.119.013572 -
Remote ischaemic conditioning for preventing and treating ischaemic stroke.
Zhao W, Zhang J, Sadowsky MG, Meng R, et al · · 2018 · cited 36× · PMID 29974450 · DOI 10.1002/14651858.cd012503.pub2 -
Induced neuroprotection by remote ischemic perconditioning as a new paradigm in ischemic stroke at the acute phase, a systematic review.
Purroy F, García C, Mauri G, Pereira C, et al · · 2020 · cited 19× · PMID 32615939 · DOI 10.1186/s12883-020-01836-8 -
Peripheral Mechanisms of Remote Ischemic Conditioning.
Yang J, Shakil F, Cho S. · · 2019 · cited 18× · PMID 32313875 -
Efficacy and safety of remote ischemic conditioning for acute ischemic stroke: A comprehensive meta-analysis from randomized controlled trials.
Kan X, Yan Z, Wang F, Tao X, et al · · 2023 · cited 17× · PMID 37183341 · DOI 10.1111/cns.14240 -
The effect of repeated remote ischemic postconditioning on infarct size in patients with an ischemic stroke (REPOST): study protocol for a randomized clinical trial.
Landman T, Schoon Y, Warlé M, De Leeuw FE, et al · · 2019 · cited 15× · PMID 30876432 · DOI 10.1186/s13063-019-3264-0 -
Ischemic stroke and intervention strategies based on the timeline of stroke progression: Review and prospects.
Xu A, Zhang H, Zhang Y, Wu J, et al · · 2025 · cited 5× · PMID 41049732 · DOI 10.1016/j.apsb.2025.07.026
Verify or expand the search:
- PubMed search for NCT02779712
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Remote ischaemic conditioning
Trials testing the same drug.
- NCT04327687 — Remote Ischemic Conditioning for Parkinson's Disease · NA · completed
Other recruiting trials for Stroke
Currently open trials in the same condition.
- NCT06615973 — Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke · recruiting
- NCT07494890 — Measurement Properties of Mechanical Cost of Walking for Individuals With Walking Impairment · NA · recruiting
- NCT07356011 — Exoskeleton for Balance · NA · recruiting
- NCT07523503 — Unilateral Versus Bilateral Task-specific Training on Motor Impairment, Upper Extremity Function, and Hand Dexterity in · NA · recruiting
- NCT06704074 — Virtual Reality Task Oriented Training on Upper Limb Function in Stroke Patients · NA · recruiting
Other University of Nottingham trials
Trials by the same sponsor.
- NCT07518381 — Medication Understanding in MS · not yet recruiting
- NCT07355556 — Technology Supported Improvement, Management and Prevention of Accidental Falls in Hospitals · not yet recruiting
- NCT07506408 — Randomised Study of Web-Based Auditory Training With Varying Perceptual and Cognitive Demands on Training Gains and Gene · NA · recruiting
- NCT07237529 — What is the Feasibility of Narrative Exposure Therapy (NET) for People Experiencing Psychosis? · NA · not yet recruiting
- NCT07237997 — Protein Supplementation During Dialysis (PROSED) · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02779712 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Nottingham
- Last refreshed: 11 October 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02779712.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing